Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,323 | -26,601 | -21,438 | -15,115 | -8,062 |
| Depreciation Amortization | 12 | 56 | 46 | 35 | 21 |
| Other Working Capital | 272 | 1,802 | 419 | 287 | 1,379 |
| Other Operating Activity | 580 | 3,190 | 2,588 | 2,279 | 1,287 |
| Operating Cash Flow | $-5,459 | $-21,553 | $-18,385 | $-12,515 | $-5,375 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | -25 | -24 | -17 | -8 |
| Investing Cash Flow | $-7 | $-25 | $-24 | $-17 | $-8 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14,870 | 18,815 | 18,787 | 3,825 | 1,917 |
| Financing Cash Flow | $14,870 | $18,815 | $18,787 | $3,825 | $1,917 |
| Beginning Cash Position | 17,791 | 20,554 | 20,554 | 20,554 | 20,554 |
| End Cash Position | 27,195 | 17,791 | 20,933 | 11,847 | 17,088 |
| Net Cash Flow | $9,404 | $-2,764 | $379 | $-8,707 | $-3,466 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,459 | -21,553 | -18,385 | -12,515 | -5,375 |
| Capital Expenditure | -7 | -25 | -24 | -17 | -8 |
| Free Cash Flow | -5,466 | -21,578 | -18,408 | -12,532 | -5,383 |